Skip to main content
logo
Racura Oncology Ltd (ASX:RAC)
Australia flag Australia · Delayed Price · Currency is AUD
2.010
-0.020 (-0.99%)
Aug 7, 2026, 3:59 PM AEST

Racura Oncology Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
3.486.044.843.130.710.39
Revenue Growth
-42.47%24.96%54.29%342.83%82.71%143.07%
Gross Profit
2.975.412.221.11-0.28-0.23
Operating Income
-8.14-4.72-13.65-10.48-11.2-6.36
Net Income
-9.39-4.79-13.82-9.92-11.2-6.34
Earnings Per Share
-0.05-0.03-0.08-0.06-0.07-0.05
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
20.9413.6717.1921.5233.549.32
Total Debt
------
Net Cash (Debt)
20.9413.6717.1921.5233.549.32
Net Cash Growth
53.24%-20.50%-20.13%-35.84%259.79%438.63%
Net Cash Per Share
0.120.080.100.130.220.07

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-7.33-4.57-9.55-10.65-6.26-4.7
Free Cash Flow
-7.33-4.57-9.55-10.65-6.26-4.7
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
85.30%89.49%45.96%35.35%-39.91%-60.07%
Operating Margin
-234.15%-78.03%-282.30%-334.22%-1582.76%-1641.48%
Pretax Margin
-270.04%-79.22%-285.76%-316.60%-1582.63%-1636.70%
Profit Margin
-270.04%-79.22%-285.76%-316.60%-1582.63%-1636.70%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
112.2233.7864.2763.73439.481360.92